Edited pig kidney keeps terminal US patient alive for 271 days

Surgeons in the United States kept 66-year-old kidney failure patient Tim Andrews alive for 271 days without dialysis after transplanting a genetically altered pig organ into his body in January 2025. The clinical trial formed part of an investigation directed by Brazilian physician Leonardo Riella, an associate professor at Harvard Medical School.
Andrews resumed chopping firewood, preparing meals, and hiking during nine months of complete independence from hemodialysis machines.
Patient background and secondary organ transplant
Prior to the procedure, the patient utilized a wheelchair and endured 18 months of intensive hospital dialysis treatments. A previous patient treated by Riella’s clinical team in 2024 survived 52 days with a xenograft before dying from an unrelated cardiac condition. The operation succeeded.
A subsequent bacterial infection unrelated to the graft forced clinical staff to decrease the patient’s immunosuppressive therapy regimens. Eighty-two days after surgeons removed the non-functional porcine organ to preserve his life from systemic immune rejection, Andrews received a conventional human kidney that continues to filter his blood without any clinical signs of organ rejection.
Bioengineering procedures behind porcine organ compatibility
The five-year animal engineering protocol approved by the Food and Drug Administration eliminated fundamental cellular barriers through three specific laboratory interventions:
- Deactivation of porcine genes that produce surface sugar molecules responsible for immediate hyperacute human rejection.
- Silencing of dormant endogenous retroviruses embedded in swine DNA to prevent transmissible infections inside human tissue.
- Insertion of seven human genes to prompt donor tissues to generate proteins recognized by the human immune system.
Riella estimated that xenotransplantation could become an accessible clinical bridge for kidney disease patients within five years. The research team aims to eliminate donor organ dependence entirely as immunosuppressive protocols advance. “We saw that an animal organ functions fully inside a human body,” Riella stated.
Transplant waiting lists and laboratory cloning progress
In Brazil, approximately 45,000 candidates currently await donor kidneys on lists coordinated by the Ministry of Health. Transplant specialist Rafael Pinheiro emphasized that cross-species transplants could eventually end reliance on deceased donors, though broad patient availability remains dependent on prolonged testing phases.
Researchers at Universidade de São Paulo announced the birth of the first cloned pig in Brazil in April at a facility in Piracicaba.
The institution’s Centro de Ciência para o Desenvolvimento em Xenotransplante completed genetic modifications on pig eggs in 2022 by silencing three swine genes and inserting seven human genes. Cloning techniques now provide the reproductive mechanism to generate identical genetically edited pigs in large quantities.







